 | • レポートコード：GIR201101645 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、生物製剤及びバイオシミラーの世界市場を調査対象にし、生物製剤及びバイオシミラーの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、ワクチン、その他）、用途別分析（腫瘍、糖尿病、心血管、血友病、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Roche、Eli Lilly、Sanofi-Aventis、Amgen、Novo Nordisk、AbbVie、Merck、Pfizer、Johnson & Johnson、Novartis、Gelgen、Ganlee、3sbio、Innovent、Biotech、Changchun High Tech、Dong Bao、CP Guojian ・メーカー別販売量、売上、市場シェア ・生物製剤及びバイオシミラーの地域別市場分析 ・生物製剤及びバイオシミラーの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・生物製剤及びバイオシミラーのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・生物製剤及びバイオシミラーのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・生物製剤及びバイオシミラーの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・生物製剤及びバイオシミラーの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・生物製剤及びバイオシミラーの種類別市場規模2015-2020：モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、ワクチン、その他 ・生物製剤及びバイオシミラーの用途別市場規模2015-2020：腫瘍、糖尿病、心血管、血友病、その他 ・生物製剤及びバイオシミラーの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019.
Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biologics and Biosimilars market has been segmented into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
By Application, Biologics and Biosimilars has been segmented into:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Biologics and Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biologics and Biosimilars are:
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Among other players domestic and global, Biologics and Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2018 and 2019.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Overview of Global Biologics and Biosimilars Market
1.4.1 Global Biologics and Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis SWOT Analysis
2.3.4 Sanofi-Aventis Product and Services
2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Product and Services
2.7.4 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Product and Services
2.9.4 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gelgen
2.11.1 Gelgen Details
2.11.2 Gelgen Major Business
2.11.3 Gelgen Product and Services
2.11.4 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ganlee
2.12.1 Ganlee Details
2.12.2 Ganlee Major Business
2.12.3 Ganlee Product and Services
2.12.4 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 3sbio
2.13.1 3sbio Details
2.13.2 3sbio Major Business
2.13.3 3sbio Product and Services
2.13.4 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Innovent
2.14.1 Innovent Details
2.14.2 Innovent Major Business
2.14.3 Innovent Product and Services
2.14.4 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biotech
2.15.1 Biotech Details
2.15.2 Biotech Major Business
2.15.3 Biotech Product and Services
2.15.4 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Changchun High Tech
2.16.1 Changchun High Tech Details
2.16.2 Changchun High Tech Major Business
2.16.3 Changchun High Tech Product and Services
2.16.4 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business
2.17.3 Dong Bao Product and Services
2.17.4 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 CP Guojian
2.18.1 CP Guojian Details
2.18.2 CP Guojian Major Business
2.18.3 CP Guojian Product and Services
2.18.4 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Biologics and Biosimilars Price by Type (2015-2020)
11 Global Biologics and Biosimilars Market Segment by Application
11.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Biologics and Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Biologics and Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2025)
12.2.4 South America Biologics and Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2025)
12.3 Biologics and Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Biologics and Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biologics and Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologics and Biosimilars Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biologics and Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Biologics and Biosimilars Major Business
Table 10. Roche Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 11. Roche SWOT Analysis
Table 12. Roche Biologics and Biosimilars Product and Services
Table 13. Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 15. Eli Lilly Biologics and Biosimilars Major Business
Table 16. Eli Lilly Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 17. Eli Lilly SWOT Analysis
Table 18. Eli Lilly Biologics and Biosimilars Product and Services
Table 19. Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 21. Sanofi-Aventis Biologics and Biosimilars Major Business
Table 22. Sanofi-Aventis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 23. Sanofi-Aventis SWOT Analysis
Table 24. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 25. Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Amgen Basic Information, Manufacturing Base and Competitors
Table 27. Amgen Biologics and Biosimilars Major Business
Table 28. Amgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 29. Amgen SWOT Analysis
Table 30. Amgen Biologics and Biosimilars Product and Services
Table 31. Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 33. Novo Nordisk Biologics and Biosimilars Major Business
Table 34. Novo Nordisk Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 35. Novo Nordisk SWOT Analysis
Table 36. Novo Nordisk Biologics and Biosimilars Product and Services
Table 37. Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AbbVie Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Biologics and Biosimilars Major Business
Table 40. AbbVie Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 41. AbbVie SWOT Analysis
Table 42. AbbVie Biologics and Biosimilars Product and Services
Table 43. AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Merck Basic Information, Manufacturing Base and Competitors
Table 45. Merck Biologics and Biosimilars Major Business
Table 46. Merck Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 47. Merck SWOT Analysis
Table 48. Merck Biologics and Biosimilars Product and Services
Table 49. Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Pfizer Basic Information, Manufacturing Base and Competitors
Table 51. Pfizer Biologics and Biosimilars Major Business
Table 52. Pfizer Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 53. Pfizer SWOT Analysis
Table 54. Pfizer Biologics and Biosimilars Product and Services
Table 55. Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 57. Johnson & Johnson Biologics and Biosimilars Major Business
Table 58. Johnson & Johnson Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 59. Johnson & Johnson SWOT Analysis
Table 60. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 61. Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Novartis Basic Information, Manufacturing Base and Competitors
Table 63. Novartis Biologics and Biosimilars Major Business
Table 64. Novartis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 65. Novartis SWOT Analysis
Table 66. Novartis Biologics and Biosimilars Product and Services
Table 67. Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Gelgen Basic Information, Manufacturing Base and Competitors
Table 69. Gelgen Biologics and Biosimilars Major Business
Table 70. Gelgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 71. Gelgen SWOT Analysis
Table 72. Gelgen Biologics and Biosimilars Product and Services
Table 73. Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Ganlee Basic Information, Manufacturing Base and Competitors
Table 75. Ganlee Biologics and Biosimilars Major Business
Table 76. Ganlee Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 77. Ganlee SWOT Analysis
Table 78. Ganlee Biologics and Biosimilars Product and Services
Table 79. Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. 3sbio Basic Information, Manufacturing Base and Competitors
Table 81. 3sbio Biologics and Biosimilars Major Business
Table 82. 3sbio Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 83. 3sbio SWOT Analysis
Table 84. 3sbio Biologics and Biosimilars Product and Services
Table 85. 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Innovent Basic Information, Manufacturing Base and Competitors
Table 87. Innovent Biologics and Biosimilars Major Business
Table 88. Innovent Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 89. Innovent SWOT Analysis
Table 90. Innovent Biologics and Biosimilars Product and Services
Table 91. Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Biotech Basic Information, Manufacturing Base and Competitors
Table 93. Biotech Biologics and Biosimilars Major Business
Table 94. Biotech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 95. Biotech SWOT Analysis
Table 96. Biotech Biologics and Biosimilars Product and Services
Table 97. Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 99. Changchun High Tech Biologics and Biosimilars Major Business
Table 100. Changchun High Tech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 101. Changchun High Tech SWOT Analysis
Table 102. Changchun High Tech Biologics and Biosimilars Product and Services
Table 103. Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 105. Dong Bao Biologics and Biosimilars Major Business
Table 106. Dong Bao Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 107. Dong Bao SWOT Analysis
Table 108. Dong Bao Biologics and Biosimilars Product and Services
Table 109. Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. CP Guojian Biologics and Biosimilars Type and Application
Table 111. CP Guojian Biologics and Biosimilars Major Business
Table 112. CP Guojian Biologics and Biosimilars Total Revenue (USD Million) (2018-2019)
Table 113. CP Guojian SWOT Analysis
Table 114. CP Guojian Biologics and Biosimilars Product and Services
Table 115. CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Global Biologics and Biosimilars Sales by Manufacturer (2018-2019) (K Units)
Table 117. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 118. Global Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 119. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 120. Global Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 121. North America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 122. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 123. North America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 124. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 125. Europe Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 126. Europe Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 127. Europe Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 128. Asia-Pacific Biologics and Biosimilars Sales by Regions (2015-2020) (K Units)
Table 129. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 130. Asia-Pacific Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 131. South America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 132. South America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 133. South America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 134. South America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 135. Middle East & Africa Biologics and Biosimilars Sales by Countries (2015-2020) (K Units)
Table 136. Middle East & Africa Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Table 137. Middle East & Africa Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 138. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Table 139. Global Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 140. Global Biologics and Biosimilars Sales Share by Type (2015-2020)
Table 141. Global Biologics and Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 142. Global Biologics and Biosimilars Revenue Share by Type (2015-2020)
Table 143. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 144. Global Biologics and Biosimilars Sales Share by Application (2015-2020)
Table 145. Global Biologics and Biosimilars Sales Forecast by Regions (2021-2025) (K Units)
Table 146. Global Biologics and Biosimilars Market Share Forecast by Regions (2021-2025)
Table 147. Global Biologics and Biosimilars Sales Forecast by Type (2021-2025) (K Units)
Table 148. Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
Table 149. Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
Table 150. Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)
Table 151. Direct Channel Pros & Cons
Table 152. Indirect Channel Pros & Cons
Table 153. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Sales Market Share of Biologics and Biosimilars by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Interferon Picture
Figure 5. Erythropoietin Picture
Figure 6. Insulin Picture
Figure 7. Vaccines Picture
Figure 8. Other Picture
Figure 9. Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 10. Tumor Picture
Figure 11. Diabetes Picture
Figure 12. Cardiovascular Picture
Figure 13. Hemophilia Picture
Figure 14. Other Picture
Figure 15. Global Biologics and Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2019
Figure 36. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 43. Global Biologics and Biosimilars Revenue Market Share by Regions in 2018
Figure 44. North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 45. Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 47. South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Figure 49. North America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020)
Figure 51. North America Biologics and Biosimilars Sales Market Share by Countries in 2018
Figure 52. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Biologics and Biosimilars Revenue Market Share by Countries in 2018
Figure 54. United States Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 60. Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Regions 2019
Figure 68. China Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 75. South America Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 76. Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Biologics and Biosimilars Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Biologics and Biosimilars Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
生物製剤創薬の世界市場 2020年 Market Overview The global Biologics Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biologics Drug Disco…- 抗炎症性生物製剤の世界市場 2020年 Market Overview The global Anti-inflammatory Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-inflammatory…
- 生物製剤医薬品開発の世界市場 2020年 Market Overview The global Biologics Drug Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biologics Drug Dev…
- 創傷治療用生物製剤の世界市場 2020年 Market Overview The Wound Care Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 脊椎用生物製剤の世界市場 2020年 Market Overview The Spine Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…